Insulin Syringes, specially take insulin for diabetics.While safety insulin syringe, RPF as well as feature of manual operation will start spontaneously in order to prevent it from reusing. Meanwhile,it is able to prevent it from hurting people by covering hypodermic needle with barrel.
Product packaging
Small Package:Full plastic / Blister
Medium Package:Medium box/Medium PE bag
Outer Package:Carton
Certifications
Company Profile
Anhui Tiankang Medical Technology Co.,Ltd (Stock Abbreviation: Tiankang Medical, Stock Code: 835942)located in Tianchang City which is rated as the pearl of Anhui.Our company have got official new three board on March 3, 2016 and now we have a registered capital of 57.78 million RMB yuan. We specialize in developing and producing products like safety syringes with retractable needles, auto disable syringes, I.V sets ,T.V sets ,extracorporeal blood circuits for haemodialysers,oral syringes, I.V catheter and intravenous infusion sets with burette etc.
Our company has a factory of more than 600 acres holding a large scaled 100,000 class clean workshop 30,000 square meters.And we now have a staff of one thousand one hundred in including 430 technical engineers of middle and high ranges(about 39% of all the staff). Besides, we now have more than 100 first-class injecting machines and affiliated equipments of assembling and packing. What deserves to be mentioned the most is that we are authorized European CE certificate (in 2002),ISO13485 certificate (in 2002) and WHO—PQS certificate (in 2010) which we hold as passports to enter international market. Our company's products began to be registered with the U.S. Food and Drug Administration in 2012 and currently rank among the best in the country for U.S. Food and Drug Administration-listed products. Autonomic products: safety syringes with retractable needles which registered by U.S. Food and Drug Administration 510 (k), disposable syringes and disposable hypodermic needles also passed U.S. Food and Drug Administration registered 510 (k). From June 6 ,2016 to June 9, with zero defect through the U.S. Food and Drug Administration field QSR 820 audit at the U.S. Food and Drug Administration site.
